Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
- 1 December 2013
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 59 (6), 1153-1159
- https://doi.org/10.1016/j.jhep.2013.07.017
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patientsHepatology International, 2012
- Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2aJournal of Hepatology, 2012
- Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2aAntiviral Therapy, 2009
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis BHepatology, 2008
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patientsHepatology, 2008
- Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factorsJournal of Hepatology, 2008
- Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigensHepatology, 2006
- Hepatitis B e Antigen-Negative Chronic Hepatitis B: Natural History and TreatmentSeminars in Liver Disease, 2006
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2004
- Interferon α Treatment and Retreatment of Hepatitis B e Antigen-Negative Chronic Hepatitis BGastroenterology, 2001